Canton, Mass.
Organogenesis broke ground on a biopharmaceutical manufacturing facility in April of 2011 in Canton, Mass. The 78,000-sf plant will use robotic and modular technologies to produce living cells used in regenerative medicine therapies. The project team includes architectural firm SMMA/Symmes Maini & McKee Associates and CRB Engineers. Completion is expected in 2013.
